| Bioactivity | (E/Z)-Eltrombopag-13C4 is a mixture complex of E-Eltrombopag and Z-Eltrombopag, with 13C labeled. Z-Eltrombopag is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag can be used for the research of cardiovascular. Eltrombopag also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag can induce apoptosis in hepatocellular carcinomab (HCC) as well[1][2][3][4][5]. | ||||||||||||
| Name | (E/Z)-Eltrombopag-13C4 | ||||||||||||
| CAS | 1217230-31-3 | ||||||||||||
| Formula | C2113C4H22N4O4 | ||||||||||||
| Molar Mass | 446.44 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
(E/Z)-Eltrombopag-13C4
CAS: 1217230-31-3 F: C2113C4H22N4O4 W: 446.44
(E/Z)-Eltrombopag-13C4 is a mixture complex of E-Eltrombopag and Z-Eltrombopag, with 13C labeled. Z-Eltrombopag is an or
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.